Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

POM121 is identified as a novel prognostic marker of oral squamous cell carcinoma.

Ma H, Li L, Jia L, Gong A, Wang A, Zhang L, Gu M, Tang G.

J Cancer. 2019 Jul 24;10(19):4473-4480. doi: 10.7150/jca.33368. eCollection 2019.

2.

High expression of TROP2 is correlated with poor prognosis of oral squamous cell carcinoma.

Tang G, Tang Q, Jia L, Xia S, Li J, Chen Y, Li H, Ding X, Wang F, Hou D, Kuai X, Feng Z, Fan Y.

Pathol Res Pract. 2018 Oct;214(10):1606-1612. doi: 10.1016/j.prp.2018.07.017. Epub 2018 Jul 25.

3.

Mechanism of lncRNA FEZF1-AS1 in promoting the occurrence and development of oral squamous cell carcinoma through targeting miR-196a.

Xu L, Hou TJ, Yang P.

Eur Rev Med Pharmacol Sci. 2019 Aug;23(15):6505-6515. doi: 10.26355/eurrev_201908_18534.

4.

Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance.

Su L, Wang Y, Xiao M, Lin Y, Yu L.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010 Oct;110(4):484-91. doi: 10.1016/j.tripleo.2010.04.009.

PMID:
20868995
5.

Collagen Triple Helix Repeat Containing-1 (CTHRC1) Expression in Oral Squamous Cell Carcinoma (OSCC): Prognostic Value and Clinico-Pathological Implications.

Lee CE, Vincent-Chong VK, Ramanathan A, Kallarakkal TG, Karen-Ng LP, Ghani WM, Rahman ZA, Ismail SM, Abraham MT, Tay KK, Mustafa WM, Cheong SC, Zain RB.

Int J Med Sci. 2015 Nov 1;12(12):937-45. doi: 10.7150/ijms.11605. eCollection 2015.

6.

Ki-67 is an independent prognostic marker for the recurrence and relapse of oral squamous cell carcinoma.

Jing Y, Zhou Q, Zhu H, Zhang Y, Song Y, Zhang X, Huang X, Yang Y, Ni Y, Hu Q.

Oncol Lett. 2019 Jan;17(1):974-980. doi: 10.3892/ol.2018.9647. Epub 2018 Oct 31.

7.

MiR-610 functions as a tumor suppressor in oral squamous cell carcinoma by directly targeting AGK.

Yao LX, Liu J, Xu L.

Eur Rev Med Pharmacol Sci. 2019 Jan;23(1):187-197. doi: 10.26355/eurrev_201901_16764.

8.

Serum miR-483-5p: a novel diagnostic and prognostic biomarker for patients with oral squamous cell carcinoma.

Xu H, Yang Y, Zhao H, Yang X, Luo Y, Ren Y, Liu W, Li N.

Tumour Biol. 2016 Jan;37(1):447-53. doi: 10.1007/s13277-015-3514-z. Epub 2015 Jul 30.

PMID:
26224475
9.

MiR-638 suppresses the progression of oral squamous cell carcinoma through wnt/β-catenin pathway by targeting phospholipase D1.

Tang KL, Tang HY, Du Y, Tian T, Xiong SJ.

Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):3278-3285. doi: 10.1080/21691401.2019.1647222.

PMID:
31379206
10.

Influence of the RPL34 gene on the growth and metastasis of oral squamous cell carcinoma cells.

Dai J, Wei W.

Arch Oral Biol. 2017 Nov;83:40-46. doi: 10.1016/j.archoralbio.2017.06.035. Epub 2017 Jun 30.

PMID:
28697409
11.

Macrophage migration inhibitory factor is a novel prognostic marker for human oral squamous cell carcinoma.

Kang Y, Zhang Y, Sun Y.

Pathol Res Pract. 2018 Aug;214(8):1192-1198. doi: 10.1016/j.prp.2018.06.020. Epub 2018 Jun 28.

PMID:
30041958
12.

Oxysophocarpine Retards the Growth and Metastasis of Oral Squamous Cell Carcinoma by Targeting the Nrf2/HO-1 Axis.

Liu R, Peng J, Wang H, Li L, Wen X, Tan Y, Zhang L, Wan H, Chen F, Nie X.

Cell Physiol Biochem. 2018;49(5):1717-1733. doi: 10.1159/000493615. Epub 2018 Sep 19.

13.

Clinical Significance and Prognostic Value of the Expression of LAMP3 in Oral Squamous Cell Carcinoma.

Lu J, Ma H, Lian S, Huang D, Lian M, Zhang Y, Huang J, Feng X.

Dis Markers. 2017;2017:1218254. doi: 10.1155/2017/1218254. Epub 2017 May 14.

14.

Inverse correlation between Naa10p and Pirh2 expression and the combined prognostic value in oral squamous cell carcinoma patients.

Zheng J, Wang F, Yang Y, Xu J, Yang J, Wang K, Liu Y, Du G, Zeng Y.

J Oral Pathol Med. 2019 Sep;48(8):686-695. doi: 10.1111/jop.12886. Epub 2019 Jun 9.

PMID:
31134698
15.

[Expression and potential clinical significance of cytidine triphosphate: phosphocholine cytidylyltransferase-α in oral squamous cell carcinoma].

Lu FC, Xie XY, Yin XM, Gao YJ.

Zhonghua Kou Qiang Yi Xue Za Zhi. 2018 Apr 9;53(4):254-258. doi: 10.3760/cma.j.issn.1002-0098.2018.04.008. Chinese.

PMID:
29690696
16.

Expression of CLIC1 as a potential biomarker for oral squamous cell carcinoma: a preliminary study.

Xu Y, Xu J, Feng J, Li J, Jiang C, Li X, Zou S, Wang Q, Li Y.

Onco Targets Ther. 2018 Nov 12;11:8073-8081. doi: 10.2147/OTT.S181936. eCollection 2018.

17.

SPARC promotes the proliferation and metastasis of oral squamous cell carcinoma by PI3K/AKT/PDGFB/PDGFRβ axis.

Jing Y, Jin Y, Wang Y, Chen S, Zhang X, Song Y, Wang Z, Pu Y, Ni Y, Hu Q.

J Cell Physiol. 2019 Jan 31. doi: 10.1002/jcp.28205. [Epub ahead of print]

PMID:
30706473
18.

Bax expression measured by AQUAnalysis is an independent prognostic marker in oral squamous cell carcinoma.

Bose P, Klimowicz AC, Kornaga E, Petrillo SK, Matthews TW, Chandarana S, Magliocco AM, Brockton NT, Dort JC.

BMC Cancer. 2012 Aug 1;12:332. doi: 10.1186/1471-2407-12-332.

19.
20.

Lysyl oxidase expression is an independent marker of prognosis and a predictor of lymph node metastasis in oral and oropharyngeal squamous cell carcinoma (OSCC).

Albinger-Hegyi A, Stoeckli SJ, Schmid S, Storz M, Iotzova G, Probst-Hensch NM, Rehrauer H, Tinguely M, Moch H, Hegyi I.

Int J Cancer. 2010 Jun 1;126(11):2653-62. doi: 10.1002/ijc.24948.

Supplemental Content

Support Center